Alleviation of IL-1beta concentration after furosemide treatment was observed in a newborn with neonatal nephrotic syndrome [50,53], patients with neuroinflammation disorders, COVID-19, and women in pregnancy [54,55,56]. Here, IL1B is linked to COVID-19.